Skip to main content
. 2019 Jun 28;98(26):e15858. doi: 10.1097/MD.0000000000015858

Table 2.

Most frequent treatment-emergent adverse events reported in at least 4 patients for up to 240 weeks of eteplirsen treatment in combined studies 201 and 202.

3.6.